166 related articles for article (PubMed ID: 16788560)
1. Molecular targets of organotin compounds in endocrine disruption: do organotin compounds function as aromatase inhibitors in mammals?
Nakanishi T; Nishikawa J; Tanaka K
Environ Sci; 2006; 13(2):89-100. PubMed ID: 16788560
[TBL] [Abstract][Full Text] [Related]
2. Endocrine disruption induced by organotin compounds; organotins function as a powerful agonist for nuclear receptors rather than an aromatase inhibitor.
Nakanishi T
J Toxicol Sci; 2008 Aug; 33(3):269-76. PubMed ID: 18670157
[TBL] [Abstract][Full Text] [Related]
3. Structure-dependent activation of peroxisome proliferator-activated receptor (PPAR) gamma by organotin compounds.
Hiromori Y; Nishikawa J; Yoshida I; Nagase H; Nakanishi T
Chem Biol Interact; 2009 Jul; 180(2):238-44. PubMed ID: 19497422
[TBL] [Abstract][Full Text] [Related]
4. Organotin compounds promote adipocyte differentiation as agonists of the peroxisome proliferator-activated receptor gamma/retinoid X receptor pathway.
Kanayama T; Kobayashi N; Mamiya S; Nakanishi T; Nishikawa J
Mol Pharmacol; 2005 Mar; 67(3):766-74. PubMed ID: 15611480
[TBL] [Abstract][Full Text] [Related]
5. Interference of endocrine disrupting chemicals with aromatase CYP19 expression or activity, and consequences for reproduction of teleost fish.
Cheshenko K; Pakdel F; Segner H; Kah O; Eggen RI
Gen Comp Endocrinol; 2008 Jan; 155(1):31-62. PubMed ID: 17459383
[TBL] [Abstract][Full Text] [Related]
6. Organotin compounds cause structure-dependent induction of progesterone in human choriocarcinoma Jar cells.
Hiromori Y; Yui H; Nishikawa J; Nagase H; Nakanishi T
J Steroid Biochem Mol Biol; 2016 Jan; 155(Pt B):190-8. PubMed ID: 25465476
[TBL] [Abstract][Full Text] [Related]
7. Trialkyltin compounds enhance human CG secretion and aromatase activity in human placental choriocarcinoma cells.
Nakanishi T; Kohroki J; Suzuki S; Ishizaki J; Hiromori Y; Takasuga S; Itoh N; Watanabe Y; Utoguchi N; Tanaka K
J Clin Endocrinol Metab; 2002 Jun; 87(6):2830-7. PubMed ID: 12050258
[TBL] [Abstract][Full Text] [Related]
8. Environmental obesogens: organotins and endocrine disruption via nuclear receptor signaling.
Grün F; Blumberg B
Endocrinology; 2006 Jun; 147(6 Suppl):S50-5. PubMed ID: 16690801
[TBL] [Abstract][Full Text] [Related]
9. Trialkyltin compounds bind retinoid X receptor to alter human placental endocrine functions.
Nakanishi T; Nishikawa J; Hiromori Y; Yokoyama H; Koyanagi M; Takasuga S; Ishizaki J; Watanabe M; Isa S; Utoguchi N; Itoh N; Kohno Y; Nishihara T; Tanaka K
Mol Endocrinol; 2005 Oct; 19(10):2502-16. PubMed ID: 15941851
[TBL] [Abstract][Full Text] [Related]
10. Cloning and characterization of retinoid X receptor (RXR) isoforms in the rock shell, Thais clavigera.
Urushitani H; Katsu Y; Ohta Y; Shiraishi H; Iguchi T; Horiguchi T
Aquat Toxicol; 2011 May; 103(1-2):101-11. PubMed ID: 21414284
[TBL] [Abstract][Full Text] [Related]
11. Tributyltin or triphenyltin inhibits aromatase activity in the human granulosa-like tumor cell line KGN.
Saitoh M; Yanase T; Morinaga H; Tanabe M; Mu YM; Nishi Y; Nomura M; Okabe T; Goto K; Takayanagi R; Nawata H
Biochem Biophys Res Commun; 2001 Nov; 289(1):198-204. PubMed ID: 11708799
[TBL] [Abstract][Full Text] [Related]
12. Developmental effects: oestrogen-induced vaginal changes and organotin-induced adipogenesis.
Iguchi T; Watanabe H; Ohta Y; Blumberg B
Int J Androl; 2008 Apr; 31(2):263-8. PubMed ID: 18248399
[TBL] [Abstract][Full Text] [Related]
13. Functional characterization of retinoid X receptor with an emphasis on the mediation of organotin poisoning in the Pacific oyster (Crassostrea gigas).
Huang W; Wu Q; Xu F; Li L; Li J; Que H; Zhang G
Gene; 2020 Aug; 753():144780. PubMed ID: 32439374
[TBL] [Abstract][Full Text] [Related]
14. Triorganotin compounds--ligands for "rexinoid" inducible transcription factors: biological effects.
Brtko J; Dvorak Z
Toxicol Lett; 2015 Apr; 234(1):50-8. PubMed ID: 25683035
[TBL] [Abstract][Full Text] [Related]
15. Some organotin compounds enhance histone acetyltransferase activity.
Osada S; Nishikawa J; Nakanishi T; Tanaka K; Nishihara T
Toxicol Lett; 2005 Feb; 155(2):329-35. PubMed ID: 15603928
[TBL] [Abstract][Full Text] [Related]
16. Aging and retinoid X receptor agonists on masculinization of female Pomacea canaliculata, with a critical appraisal of imposex evaluation in the Ampullariidae.
Giraud-Billoud M; Castro-Vazquez A
Ecotoxicol Environ Saf; 2019 Mar; 169():573-582. PubMed ID: 30476819
[TBL] [Abstract][Full Text] [Related]
17. Organotin compounds enhance 17beta-hydroxysteroid dehydrogenase type I activity in human choriocarcinoma JAr cells: potential promotion of 17beta-estradiol biosynthesis in human placenta.
Nakanishi T; Hiromori Y; Yokoyama H; Koyanagi M; Itoh N; Nishikawa J; Tanaka K
Biochem Pharmacol; 2006 Apr; 71(9):1349-57. PubMed ID: 16513093
[TBL] [Abstract][Full Text] [Related]
18. Structural basis for PPARγ transactivation by endocrine-disrupting organotin compounds.
Harada S; Hiromori Y; Nakamura S; Kawahara K; Fukakusa S; Maruno T; Noda M; Uchiyama S; Fukui K; Nishikawa J; Nagase H; Kobayashi Y; Yoshida T; Ohkubo T; Nakanishi T
Sci Rep; 2015 Feb; 5():8520. PubMed ID: 25687586
[TBL] [Abstract][Full Text] [Related]
19. Imposex development in Nucella lapillus--evidence for the involvement of retinoid X receptor and androgen signalling pathways in vivo.
Stange D; Sieratowicz A; Oehlmann J
Aquat Toxicol; 2012 Jan; 106-107():20-4. PubMed ID: 22057251
[TBL] [Abstract][Full Text] [Related]
20. Plasma biomarkers in juvenile marine fish provide evidence for endocrine modulation potential of organotin compounds.
Min BH; Kim BM; Kim M; Kang JH; Jung JH; Rhee JS
Comp Biochem Physiol C Toxicol Pharmacol; 2018 Aug; 210():35-43. PubMed ID: 29746996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
